How to Read a Certificate of Analysis

A Certificate of Analysis (COA) is a document issued by a manufacturer or testing laboratory that reports the results of quality-control testing performed on a specific batch of a chemical product. For peptides, the COA is the primary means of verifying that a product is what it claims to be, that it meets stated purity standards, and that it is free from harmful contaminants such as bacteria and endotoxins.

Whether you are a researcher evaluating a peptide for laboratory use, a clinician reviewing a compounded pharmaceutical, or a patient reviewing a product prescribed from a compounding pharmacy, understanding how to read a COA is an essential skill. This guide breaks down each section of a typical peptide COA and explains what to look for -- and what should raise concerns.

Why the COA Matters

Unlike FDA-approved drugs, which are manufactured under rigorously enforced Current Good Manufacturing Practice (cGMP) regulations and inspected by FDA auditors, many peptides on the market come from compounding pharmacies or research chemical suppliers that operate under less stringent oversight. The COA is often the only analytical evidence that a given batch meets quality standards.[1]

A thorough COA should demonstrate three things:

1. Identity -- the product is actually the peptide it claims to be (confirmed by mass spectrometry)
2. Purity -- the product contains the stated amount of the target peptide with minimal impurities (confirmed by HPLC)
3. Safety -- the product is free from microbial contamination and endotoxins (confirmed by sterility and LAL testing)

Identity Testing: Mass Spectrometry

Mass spectrometry (MS) is the gold standard for confirming that a peptide product is the correct molecule. The technique works by ionizing the peptide molecules and measuring their mass-to-charge ratio, which yields a precise measurement of molecular weight.

On a COA, you will typically see two values:

• Expected (theoretical) molecular weight -- calculated from the known amino acid sequence. For example, BPC-157 has a theoretical molecular weight of 1419.53 Da.
• Observed molecular weight -- the value actually measured by the mass spectrometer.

For a valid identity confirmation, the observed molecular weight should match the expected value within the instrument's tolerance, typically ±0.1% or ±1-2 Da for peptides tested by electrospray ionization mass spectrometry (ESI-MS) or matrix-assisted laser desorption/ionization (MALDI). If the observed value differs significantly from the expected value, the product may be the wrong peptide, a truncated sequence, or a degraded product.[2]

Purity Testing: HPLC

High-Performance Liquid Chromatography (HPLC) is the standard method for assessing peptide purity. HPLC works by dissolving the peptide in a solvent and passing it through a column packed with stationary-phase material. Different components in the mixture travel through the column at different rates, separating them by their chemical properties. A UV detector at the end of the column measures the absorbance of each component as it elutes, generating a chromatogram -- a graph of absorbance versus time.

The main peak in the chromatogram corresponds to the target peptide. Smaller peaks represent impurities -- deletion sequences, truncated peptides, oxidized variants, or other by-products of synthesis. Purity is calculated as the area of the main peak divided by the total area of all peaks, expressed as a percentage.[3]

Understanding Purity Percentages

• >98% purity -- pharmaceutical grade or near-pharmaceutical grade. This is the standard for compounded injectable peptides and high-quality research peptides. Impurities at this level are minimal and unlikely to cause adverse effects.
• 95-98% purity -- research grade. Acceptable for many laboratory applications but may contain enough impurities to affect sensitive biological assays. Some compounding pharmacies accept this level.
• <95% purity -- lower grade. Not generally acceptable for injection. The impurities may include potentially bioactive fragments or toxic synthesis by-products such as trifluoroacetic acid (TFA) residues.

A complete COA should include the HPLC chromatogram image (the actual graph, not just a number), the column type and conditions used, the retention time of the main peak, and the calculated purity percentage. Some suppliers report only the purity percentage without the chromatogram -- while not necessarily fraudulent, this omission prevents independent verification.

Microbial Testing

Any peptide intended for injection must be sterile -- free from viable bacteria, fungi, and other microorganisms. Microbial testing is performed according to USP (United States Pharmacopeia) standards, specifically USP <71> Sterility Tests and USP <61>/<62> Microbial Enumeration and Specified Organism Tests.

The COA should report:

• Total Aerobic Microbial Count (TAMC) -- the total number of aerobic bacteria detected, expressed in colony-forming units per gram or mL (CFU/g or CFU/mL). For injectable products, this should be <1 CFU/mL (i.e., no growth detected).
• Total Yeast and Mold Count (TYMC) -- same measurement for fungal organisms. Should also show no growth for injectables.
• Specified organisms -- absence of specific pathogens such as Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, and Salmonella species.

Some COAs will simply state "Sterile" or "Pass" for the sterility test. While this is better than no testing, a detailed report with methodology is preferable.

Endotoxin Testing (LAL)

Endotoxins are components of the outer cell membrane of gram-negative bacteria. Even after bacteria are killed by sterilization, endotoxins can persist in solution and cause serious immune reactions when injected, including fever, inflammatory cascade activation, and in severe cases, septic shock. Therefore, endotoxin testing is a critical component of any injectable product's quality assurance.

The standard endotoxin test is the Limulus Amebocyte Lysate (LAL) test, which uses a lysate from the blood cells of the horseshoe crab (Limulus polyphemus) that gels in the presence of endotoxins. Results are measured in Endotoxin Units per milliliter (EU/mL).[4]

The FDA limit for injectable drugs is generally <5 EU/kg body weight/hour. For most peptide products, the COA should show endotoxin levels well below this threshold, typically reported as <0.25 EU/mL or <0.5 EU/mL. Any value exceeding 5 EU/mL is cause for concern.

Red Flags: When to Be Suspicious

Not all COAs are created equal. Some are incomplete, and some may be fabricated. Here are the key red flags to watch for:

1. Missing tests. A credible COA for an injectable peptide should include at minimum: mass spectrometry identity confirmation, HPLC purity, sterility testing, and endotoxin (LAL) testing. If any of these are absent, the COA is incomplete.
2. No laboratory name or accreditation. The COA should identify the testing laboratory by name and provide accreditation information (such as ISO 17025 or GLP compliance). If the COA has no laboratory identification, it cannot be independently verified.
3. Suspiciously round numbers. Analytical measurements inherently produce specific values. A purity of "99.0000%" or an endotoxin result of "0.000 EU/mL" is unrealistically precise and may indicate fabricated data. Real results look like "98.73%" or "<0.25 EU/mL."
4. No chromatogram or spectrum images. A purity percentage without the HPLC chromatogram, or a molecular weight without the mass spectrum, cannot be independently verified. Reputable suppliers include the raw analytical data.
5. Generic or templated appearance. If every COA from a supplier looks identical except for the product name and lot number -- same purity to the decimal, same formatting, same results -- it may be a template rather than actual batch-specific testing.
6. No batch/lot number. Each COA should be tied to a specific manufacturing lot. Without a lot number, there is no way to verify that the testing corresponds to the product you received.
7. Date discrepancies. The testing date should be near the manufacturing date and before the product's stated expiration. A COA dated years before the product sale, or with no date at all, is suspect.

Third-Party Testing

The most reliable COAs come from independent, third-party testing laboratories rather than from the manufacturer itself. Third-party labs have no financial interest in the results and are subject to their own accreditation standards. ISO 17025-accredited laboratories follow internationally recognized standards for testing and calibration.

Some reputable peptide suppliers proactively send samples from each batch to independent labs and publish both the in-house and third-party COAs. If you are evaluating a supplier, the willingness to provide third-party COAs on request is a strong indicator of product quality and transparency.

For researchers and clinicians who want the highest level of assurance, it is possible to submit samples for independent testing through commercial analytical labs that specialize in peptide characterization. This adds cost and time but provides the most definitive quality verification.

Video Resources

These videos from trusted educators provide additional context on the topics covered in this guide.